Monday, June 1, 2020

Gilead's Remdesivir Shows Fair Improvement In Moderate COVID-19 Patients

Gilead Sciences Inc on Monday reported that its antiviral drug remdesivir provided a modest benefit in patients with moderate COVID-19 given a five-day course of the treatment, while those who...

from NDTV News - World-news https://ift.tt/36PjXS6
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Man Not Speaking To Wife For Days Not Cruelty: Supreme Court In Suicide Case

The man had not been on talking terms with his wife for 13 days, which led to her death by suicide. from NDTV News Search Records Found 10...